These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 30854041

  • 1. Human epidermal growth factor receptor 2 amplification as a biomarker for treatment in patients with lymph node-metastatic penoscrotal extramammary Paget's disease.
    Lu X, Zhang P, Zhu Y, Ye D.
    Oncol Lett; 2019 Mar; 17(3):2677-2686. PubMed ID: 30854041
    [Abstract] [Full Text] [Related]

  • 2. Extramammary Paget's Disease in Two Brothers.
    Zhang X, Jin W, Zhu H, Yu H.
    Indian J Dermatol; 2015 Mar; 60(4):423. PubMed ID: 26288451
    [Abstract] [Full Text] [Related]

  • 3. Experiences of trastuzumab plus paclitaxel combination therapy in metastatic human epidermal growth factor receptor 2-positive extramammary Paget's disease: Four cases and a review.
    Sekiguchi N, Kubota S, Noguchi T, Fukushima T, Kobayashi T, Kanda S, Koizumi T, Miyake T, Shirai T, Okuyama R.
    J Dermatol; 2020 Nov; 47(11):1276-1279. PubMed ID: 32706146
    [Abstract] [Full Text] [Related]

  • 4. Successful and long-term response to trastuzumab plus paclitaxel combination therapy in human epidermal growth factor receptor 2-positive extramammary Paget's disease: A case report and review of the literature.
    Ichiyama T, Gomi D, Fukushima T, Kobayashi T, Sekiguchi N, Sakamoto A, Sasaki S, Mamiya K, Koizumi T, Hama Y.
    Mol Clin Oncol; 2017 Nov; 7(5):763-766. PubMed ID: 29181166
    [Abstract] [Full Text] [Related]

  • 5. A Case of Metastatic Extramammary Paget's Disease Responding to Trastuzumab plus Paclitaxel Combination Therapy.
    Hanawa F, Inozume T, Harada K, Kawamura T, Shibagaki N, Shimada S.
    Case Rep Dermatol; 2011 Sep; 3(3):223-7. PubMed ID: 22135629
    [Abstract] [Full Text] [Related]

  • 6. Human epidermal growth factor receptor 2 protein overexpression and gene amplification in extramammary Paget disease.
    Tanaka R, Sasajima Y, Tsuda H, Namikawa K, Tsutsumida A, Otsuka F, Yamazaki N.
    Br J Dermatol; 2013 Jun; 168(6):1259-66. PubMed ID: 23360223
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Metastatic extramammary Paget's disease treated with paclitaxel and trastuzumab combination chemotherapy.
    Takahagi S, Noda H, Kamegashira A, Madokoro N, Hori I, Shindo H, Mihara S, Hide M.
    J Dermatol; 2009 Aug; 36(8):457-61. PubMed ID: 19691751
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinicopathological characteristics, management and outcome of metastatic penoscrotal extramammary Paget's disease.
    Zhu Y, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL, Shen YJ, Mao HR.
    Br J Dermatol; 2009 Sep; 161(3):577-82. PubMed ID: 19438449
    [Abstract] [Full Text] [Related]

  • 11. HER2-Targeted Antibody-Drug Conjugates Display Potent Antitumor Activities in Preclinical Extramammary Paget's Disease Models: In Vivo and Immunohistochemical Analyses.
    Tokuchi K, Maeda T, Kitamura S, Yanagi T, Ujiie H.
    Cancers (Basel); 2022 Jul 20; 14(14):. PubMed ID: 35884581
    [Abstract] [Full Text] [Related]

  • 12. Phase II clinical trial of docetaxel and trastuzumab for HER2-positive advanced extramammary Paget's disease (EMPD-HER2DOC).
    Hirai I, Tanese K, Nakamura Y, Fukuda K, Ouchi T, Hayashida T, Kameyama K, Abe T, Amagai M, Funakoshi T.
    Oncologist; 2024 Sep 06; 29(9):e1201-e1208. PubMed ID: 38823035
    [Abstract] [Full Text] [Related]

  • 13. Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2S310F mutated extramammary Paget's disease.
    Nordmann TM, Messerli-Odermatt O, Meier L, Micaletto S, Coppetti T, Nägeli M, Kamarachev J, Kudura K, Freiberger SN, Rordorf T, Mangana J, Braun R, Dummer R.
    Oncotarget; 2019 Nov 19; 10(62):6647-6650. PubMed ID: 31803359
    [Abstract] [Full Text] [Related]

  • 14. Metastatic Extramammary Paget's Disease of Scrotum Responds Completely to Single Agent Trastuzumab in a Hemodialysis Patient: Case Report, Molecular Profiling and Brief Review of the Literature.
    Barth P, Dulaimi Al-Saleem E, Edwards KW, Millis SZ, Wong YN, Geynisman DM.
    Case Rep Oncol Med; 2015 Nov 19; 2015():895151. PubMed ID: 25692060
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of positron emission tomography imaging to detect lymph node metastases in patients with extramammary Paget's disease.
    Fujiwara M, Suzuki T, Senoo A, Fukamizu H, Tokura Y.
    J Dermatol; 2017 Aug 19; 44(8):939-943. PubMed ID: 28295555
    [Abstract] [Full Text] [Related]

  • 17. Superficial circumflex iliac artery perforator propeller flap for penoscrotal extramammary Paget's disease.
    Dong W, Xiao X, Wang Z, Yang X, Bi H.
    Int J Dermatol; 2024 Jul 15. PubMed ID: 39010187
    [Abstract] [Full Text] [Related]

  • 18. Mammary Paget's disease and extra-mammary Paget's disease: two morphologically similar but biologically different diseases.
    Liu W, Iqbal J, Khoury T.
    J Cutan Pathol; 2010 Nov 15; 37(11):1145-9. PubMed ID: 19719834
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.